Brian Shoichet, PhD
Professor
Pharmaceutical Chemistry
School of Pharmacy

bshoichet@gmail.com 415-514-4126

The Shoichet lab seeks to discover chemical reagents that can illuminate biological problems. A longstanding effort to do so is by exploiting protein structures to predict new reagents and therapeutic leads (structure-based ligand discovery). Two ongoing projects are 1. Developing new computational methods for ligand discovery and 2.

Show full bio (220 words) Hide full bio

Applying these to G-Protein Coupled Receptors (GPCRs), which are the single largest family of signaling receptors in human cells.

Allied with this effort is an experimental research program that 3. Tests the new methods in well-controlled systems, determining x-ray crystal structures and measuring binding thermodynamics. The experimental program has led to unexpected discoveries, including the observation that many drugs and reagents can form colloidal aggregates in solution. This has led us to investigate 4. How the physical organic chemistry of drugs affects their behavior in vitro and in vivo, influencing drug delivery and formulation.

A new effort turns the entire structural view on its head, 5. Developing computational methods to relate receptors by the similarity of their ligands, rather than by protein sequence or structure. This changes pharmacological relationships dramatically—targets that would normally be considered sequence neighbors are pushed far apart (because their ligands are dissimilar), whereas other targets that supposedly have nothing to do with one another become neighbors (because their ligands are very similar). Since the new relationships are articulated by ligands, they may be directly tested both on isolated receptors and, increasingly, against model whole organisms, such as zebra fish, C. elegans and mice. This project seeks to discover the integrated chemical circuits through which drugs and reagents affect whole organisms. "

Awards

Show all (10) Hide

  • Society for Biomolecular Sciences Accomplishment Award, 2011
  • Topliss Lectureship, University of Michigan, 2011
  • Abbott Lectureship, Yale University, 2009
  • Swiss Universities 3e Cycle en Chimie (Lausanne, Bern, Friborg, Geneva), 2008
  • Novartis Chemistry Lecturer (Cambridge, Basel, Vienna, Horsham, Tsukuba, Emeryville), 2006-2007
  • Astra Lectureship, University of Ottawa, 2004
  • Dean’s Award for Teaching Excellence, Northwestern University, 2001
  • CAREER Award, National Science Foundation, 1998-2003
  • Career Development Award, PhRMA Foundation, 1997-1999
  • Damon Runyon-Walter Winchell Cancer Research Fellow, 1993-1996

Education & Training

Show all (1) Hide

  • Ph.D. Graduate Division (Pharmaceutical Chemistry) University of California, San Francisco 1991

Grants and Projects

Show all (12) Hide

Publications (287)

Top publication keywords:
Enzyme InhibitorsCrystallography, X-RayDrug DesignBinding SitesProteinsSmall Molecule LibrariesBacterial ProteinsDrug DiscoveryProtein BindingLigandsMolecular Docking Simulationbeta-Lactamasesbeta-Lactamase InhibitorsColloidsModels, Molecular

Show all (282 more) Hide